Head of the Brain Metastasis Group at CNIO. He investigates the biology of brain metastasis in order to challenge this unmet clinical need using his background in Neuroscience and Cancer Biology. Specifically, his laboratory studies novel brain metastasis mediators, characterizes the metastasis-associated microenvironment, designs better experimental models and explores novel methods to target brain metastasis, including the frequent impact on brain activity. All these aims consider the brain environment as a critical component to understand the biology of this progression of cancer. Dr. Valiente has co-founded the first National Network of Brain Metastasis (RENACER) in Spain, which is allowing his team to speed up the translation of laboratory findings to the clinic in collaboration with the 18 hospitals associated. His contributions to brain metastasis research have been recognized with the Constantes y Vitales Award, Banco Sabadell Award, ASPIRE Award, ERC CoG, EMBO YIP, CLIP Award, Beug Foundation’s Prize for Metastasis Research, Bristol-Myers Squibb-MRA Young Investigator Award among others.
He is Board Member of European Association of Neuro-Oncology (EANO) and Board Member of the Metastasis Research Society (MRS).
Tuesday, 17 June 2025
| Time |
Session |
|
|
09:20
10:55
|
-
Identifying and targeting metabolic vulnerabilities in leptomeningeal metastasis
-
Proffered Paper: Selected from Abstracts - to be announced in 2025
-
Strategies to challenge brain metastases in mice and human
-
Proffered Paper: Selected from Abstracts - to be announced in 2025
-
Title to be announced
Auditorium 2
|
|
14:25
15:15
|
(open to EACR Early Career & Student Members, pre-registration required)
-
TABLE 1: Efficient and caring mentorship: how to make your research team flourish?
-
TABLE 2: Leadership: Experience of a former EACR president
-
TABLE 3: Leadership: Experience in combining research with the direction of a research institute
-
TABLE 5: How to effectively lead a large research group and handle leadership responsibilities
-
TABLE 6: Challenges of starting a new lab and becoming a PI abroad
-
TABLE 7: Experience of creating a biomedical start-up in parallel to leading a research team
-
TABLE 8: The challenges of opening your own lab
-
TABLE 9: ERC funding opportunities for starting or establishing a research group in the EU or Associated Countries
-
TABLE 10: Lessons from My Journey: Navigating Data Science & Bioinformatics Careers in Pharma
-
TABLE 4: How to make your research transferable to the clinic
Career Discovery Area
|
